AbelZeta Pharma

Pipeline

China

US

Global

INFLAMMATORY & IMMUNOLOGICAL
DISEASES

*C-CAR168 is in early development and is available only in the setting of clinical trials

Hematology Malignancies

Solid Tumors

Scroll to Top